Macerich Co
F:M6G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Macerich Co
F:M6G
|
US |
|
A
|
Active Biotech AB publ
SWB:BTPC
|
SE |
|
I
|
Interpublic Group of Companies Inc
DUS:IPG
|
US |
|
H
|
Heidelberg Pharma AG
F:HPHA
|
DE |
|
Protalix Biotherapeutics Inc
F:PBDA
|
US |
|
A
|
Allstate Corp
F:ALS
|
US |
|
Meituan
F:9MD
|
CN |
|
Varonis Systems Inc
NASDAQ:VRNS
|
US |
|
C
|
CVS Health Corp
F:CVS
|
US |
|
A
|
Amcor PLC
XBER:485
|
UK |
|
C
|
Companhia Energetica de Minas Gerais CEMIG
NYSE:CIG
|
BR |
|
ON Semiconductor Corp
NASDAQ:ON
|
US |
|
Recruit Holdings Co Ltd
F:1RHA
|
JP |
|
C
|
Cogent Communications Holdings Inc
F:OGM1
|
US |
|
O
|
Old Dominion Freight Line Inc
F:ODF
|
US |
|
A
|
ACS Actividades de Construccion y Servicios SA
DUS:OCI1
|
ES |
|
H
|
Harvey Norman Holdings Ltd
XMUN:HNN
|
AU |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
US |
|
C
|
China Life Insurance Co Ltd
XMUN:CHL
|
CN |
|
A
|
Amdocs Ltd
F:AOS
|
US |
|
FibroGen Inc
NASDAQ:KYNB
|
US |
|
D
|
Dillard's Inc
XMUN:DL7A
|
US |
|
A
|
Active Biotech AB publ
F:BTPC
|
SE |
|
A
|
Ageas SA
OTC:AGESY
|
BE |
Wall St Price Targets
M6G Price Targets Summary
Macerich Co
According to Wall Street analysts, the average 1-year price target for M6G is 18.02 EUR with a low forecast of 13.74 EUR and a high forecast of 22.69 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is M6G's stock price target?
Price Target
18.02
EUR
According to Wall Street analysts, the average 1-year price target for M6G is 18.02 EUR with a low forecast of 13.74 EUR and a high forecast of 22.69 EUR.
What is the Revenue forecast for Macerich Co?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Macerich Co?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 8 years is 7%.
